[
  {
    "ts": null,
    "headline": "Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth",
    "url": "https://finnhub.io/api/news?id=065f19d0de16582a2b6bfe2fb3d72df9a97383ba230562ce84159e0c11a57dd6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755121860,
      "headline": "Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know",
      "id": 136345193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth",
      "url": "https://finnhub.io/api/news?id=065f19d0de16582a2b6bfe2fb3d72df9a97383ba230562ce84159e0c11a57dd6"
    }
  },
  {
    "ts": null,
    "headline": "Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y",
    "summary": "TBPH posts better-than-expected second-quarter 2025 results, boosted by Yupelri sales and licensing gains.",
    "url": "https://finnhub.io/api/news?id=81df43a05f37f8ddf11b9e7a0ef9053b07214fb992c99e6dff73eeaded288eb9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755102660,
      "headline": "Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y",
      "id": 136340308,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "TBPH posts better-than-expected second-quarter 2025 results, boosted by Yupelri sales and licensing gains.",
      "url": "https://finnhub.io/api/news?id=81df43a05f37f8ddf11b9e7a0ef9053b07214fb992c99e6dff73eeaded288eb9"
    }
  },
  {
    "ts": null,
    "headline": "VTRS Q2 Deep Dive: Pipeline Progress and Cost Discipline Drive Results Amid Industry Headwinds",
    "summary": "Medication company Viatris (NASDAQ:VTRS) announced better-than-expected revenue in Q2 CY2025, but sales fell by 5.6% year on year to $3.58 billion. The company expects the full year’s revenue to be around $13.75 billion, close to analysts’ estimates. Its non-GAAP profit of $0.62 per share was 11.4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=ac9ad57e41939f673868a63f937a71ba0b74285a20b3f88cb5bd306715ee998d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755058981,
      "headline": "VTRS Q2 Deep Dive: Pipeline Progress and Cost Discipline Drive Results Amid Industry Headwinds",
      "id": 136328897,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Medication company Viatris (NASDAQ:VTRS) announced better-than-expected revenue in Q2 CY2025, but sales fell by 5.6% year on year to $3.58 billion. The company expects the full year’s revenue to be around $13.75 billion, close to analysts’ estimates. Its non-GAAP profit of $0.62 per share was 11.4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=ac9ad57e41939f673868a63f937a71ba0b74285a20b3f88cb5bd306715ee998d"
    }
  }
]